Arginine-rich motifs are not required for hepatitis delta virus RNA binding activity of the hepatitis delta antigen

Journal of Virology

Volumn 87, Issue 15, 2013, Pages 8665-8674

  Daigh, Leighton H ^a   Griffin, Brittany L ^a   Soroush, Ali ^a   Mamedov, Murad R ^a,b   Casey, John L ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS DELTA ANTIGEN;

AMINO TERMINAL SEQUENCE; ARGININE RICH MOTIF; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; HEPATITIS DELTA VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR RECOGNITION; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN RNA BINDING; RNA BINDING; SITE DIRECTED MUTAGENESIS;

AMINO ACID MOTIFS; ARGININE; CELL LINE; DNA MUTATIONAL ANALYSIS; HEPATITIS DELTA ANTIGENS; HEPATITIS DELTA VIRUS; HUMANS; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; RNA, VIRAL; RNA-BINDING PROTEINS; SEQUENCE DELETION;

EID: 84880593373     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00929-13     Document Type: Article

References (63)

1. Kuo MY, Goldberg J, Coates L, Mason W, Gerin J, Taylor J. 1988. Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications. J. Virol. 62:1855-1861.
2. Wang KS, Choo QL, Weiner AJ, Ou JH, Najarian RC, Thayer RM, Mullenbach GT, Denniston KJ, Gerin JL, Houghton M. 1986. Structure, sequence and expression of the hepatitis delta viral genome. Nature 323: 508-514.
3. Tseng CH, Lai MM. 2009. Hepatitis delta virus RNA replication. Viruses 1:818-831.
4. Taylor J, Pelchat M. 2010. Origin of hepatitis delta virus. Future Microbiol. 5:393-402.
5. Chang MF, Baker SC, Soe LH, Kamahora T, Keck JG, Makino S, Govindarajan S, Lai MM. 1988. Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J. Virol. 62:2403-2410.
6. Chao M, Hsieh SY, Taylor J. 1991. The antigen of hepatitis delta virus: examination of in vitro RNA-binding specificity. J. Virol. 65:4057-4062.
7. Lazinski DW, Taylor JM. 1993. Relating structure to function in the hepatitis delta virus antigen. J. Virol. 67:2672-2680.
8. Lee CZ, Lin JH, Chao M, McKnight K, Lai MM. 1993. RNA-binding activity of hepatitis delta antigen involves two arginine-rich motifs and is required for hepatitis delta virus RNA replication. J. Virol. 67:2221-2227.
9. Wang JG, Lemon SM. 1993. Hepatitis delta virus antigen forms dimers and multimeric complexes in vivo. J. Virol. 67:446-454.
10. Bichko VV, Lemon SM, Wang JG, Hwang S, Lai MM, Taylor JM. 1996. Epitopes exposed on hepatitis delta virus ribonucleoproteins. J. Virol. 70: 5807-5811.
11. Wang HW, Chen PJ, Lee CZ, Wu HL, Chen DS. 1994. Packaging of hepatitis delta virus RNA via the RNA-binding domain of hepatitis delta antigens: different roles for the small and large delta antigens. J. Virol. 68:6363-6371.
12. Chou HC, Hsieh TY, Sheu GT, Lai MM. 1998. Hepatitis delta antigen mediates the nuclear import of hepatitis delta virus RNA. J. Virol. 72: 3684-3690.
13. Cao D, Haussecker D, Huang Y, Kay MA. 2009. Combined proteomic-RNAi screen for host factors involved in human hepatitis delta virus replication. RNA 15:1971-1979.
14. Yamaguchi Y, Filipovska J, Yano K, Furuya A, Inukai N, Narita T, Wada T, Sugimoto S, Konarska MM, Handa H. 2001. Stimulation of RNA polymerase II elongation by hepatitis delta antigen. Science 293: 124-127.
15. Yamaguchi Y, Delehouzee S, Handa H. 2002. HIV and hepatitis delta virus: evolution takes different paths to relieve blocks in transcriptional elongation. Microbes Infect. 4:1169-1175.
16. Zhang C, Yan H, Burton ZF. 2003. Combinatorial control of human RNA polymerase II (RNAP II) pausing and transcript cleavage by transcription factor IIF, hepatitis delta antigen, and stimulatory factor II. J. Biol. Chem. 278:50101-50111.
17. Nedialkov YA, Gong XQ, Hovde SL, Yamaguchi Y, Handa H, Geiger JH, Yan H, Burton ZF. 2003. NTP-driven translocation by human RNA polymerase II. J. Biol. Chem. 278:18303-18312.
18. Chang MF, Chen CH, Lin SL, Chen CJ, Chang SC. 1995. Functional domains of delta antigens and viral RNA required for RNA packaging of hepatitis delta virus. J. Virol. 69:2508-2514.
19. Lazinski DW, Taylor JM. 1994. Expression of hepatitis delta virus RNA deletions: cis and trans requirements for self-cleavage, ligation, and RNA packaging. J. Virol. 68:2879-2888.
20. Xia YP, Lai MM. 1992. Oligomerization of hepatitis delta antigen is required for both the trans-activating and trans-dominant inhibitory activities of the delta antigen. J. Virol. 66:6641-6648.
21. Chao M, Hsieh SY, Taylor J. 1990. Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication. J. Virol. 64:5066-5069.
22. Chen PJ, Chang FL, Wang CJ, Lin CJ, Sung SY, Chen DS. 1992. Functional study of hepatitis delta virus large antigen in packaging and replication inhibition: role of the amino-terminal leucine zipper. J. Virol. 66:2853-2859.
23. Glenn JS, White JM. 1991. trans-dominant inhibition of human hepatitis delta virus genome replication. J. Virol. 65:2357-2361.
24. Glenn JS, Watson JA, Havel CM, White JM. 1992. Identification of a prenylation site in delta virus large antigen. Science 256:1331-1333.
25. Lin JH, Chang MF, Baker SC, Govindarajan S, Lai MM. 1990. Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J. Virol. 64:4051-4058.
26. Huang ZS, Wu HN. 1998. Identification and characterization of the RNA chaperone activity of hepatitis delta antigen peptides. J. Biol. Chem. 273: 26455-26461.
27. Wang CC, Chang TC, Lin CW, Tsui HL, Chu PB, Chen BS, Huang ZS, Wu HN. 2003. Nucleic acid binding properties of the nucleic acid chaperone domain of hepatitis delta antigen. Nucleic Acids Res. 31:6481-6492.
28. Poisson F, Roingeard P, Baillou A, Dubois F, Bonelli F, Calogero RA, Goudeau A. 1993. Characterization of RNA-binding domains of hepatitis delta antigen. J. Gen. Virol. 74:2473-2478.
29. Taylor JM, Farci P, Purcell RH. 2007. Hepatitis delta virus, p 3031-3046. In KnipeDM(ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
30. Taylor JM. 2009. Chapter 3. Replication of the hepatitis delta virus RNA genome. Adv. Virus Res. 74:103-121.
31. Rizzetto M. 2009. Hepatitis D: thirty years after. J. Hepatol. 50:1043-1050.
32. Greco-Stewart V, Pelchat M. 2010. Interaction of host cellular proteins with components of the hepatitis delta virus. Viruses 2:189-212.
33. Defenbaugh DA, Johnson M, Chen R, Zheng YY, Casey JL. 2009. Hepatitis delta antigen requires a minimum length of the hepatitis delta virus unbranched rod RNA structure for binding. J. Virol.83:4548-4556.
34. Alves C, Cheng H, Roder H, Taylor J. 2010. Intrinsic disorder and oligomerization of the hepatitis delta virus antigen. Virology 407:333-340.
35. Zuccola HJ, Rozzelle JE, Lemon SM, Erickson BW, Hogle JM. 1998. Structural basis of the oligomerization of hepatitis delta antigen. Structure 6:821-830.
36. Cornillez-Ty CT, Lazinski DW. 2003. Determination of the multimerization state of the hepatitis delta virus antigens in vivo. J. Virol. 77:10314-10326.
37. Lin BC, Defenbaugh DA, Casey JL. 2010. Multimerization of hepatitis delta antigen is a critical determinant of RNA binding specificity. J. Virol.84:1406-1413.
38. Ryu WS, Netter HJ, Bayer M, Taylor J. 1993. Ribonucleoprotein complexes of hepatitis delta virus. J. Virol. 67:3281-3287.
39. Gudima S, Chang J, Moraleda G, Azvolinsky A, Taylor J. 2002. Parameters of human hepatitis delta virus genome replication: the quantity, quality, and intracellular distribution of viral proteins and RNA. J. Virol. 76:3709-3719.
40. Polson AG, Ley HL, III, Bass BL, Casey JL. 1998. Hepatitis delta virus RNA editing is highly specific for the amber/W site and is suppressed by hepatitis delta antigen. Mol. Cell. Biol. 18:1919-1926.
41. Jayan GC, Casey JL. 2002. Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression. J. Virol. 76:12399-12404.
42. Casey JL, Gerin JL. 1995. Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA. J. Virol. 69:7593-7600.
43. Polson AG, Bass BL, Casey JL. 1996. RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature 380:454-456.
44. Jayan GC, Casey JL. 2005. Effects of conserved RNA secondary structures on hepatitis delta virus genotype I RNA editing, replication, and virus production. J. Virol. 79:11187-11193.
45. Bergmann KF, Cote PJ, Moriarty A, Gerin JL. 1989. Hepatitis delta antigen. Antigenic structure and humoral immune response. J. Immunol. 143:3714-3721.
46. Amir-Ahmady B, Boutz PL, Markovtsov V, Phillips ML, Black DL. 2005. Exon repression by polypyrimidine tract binding protein. RNA 11: 699-716.
47. Sato S, Wong SK, Lazinski DW. 2001. Hepatitis delta virus minimal substrates competent for editing by ADAR1 and ADAR2. J. Virol. 75: 8547-8555.
48. Wong SK, Lazinski DW. 2002. Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1. Proc. Natl. Acad. Sci. U. S. A. 99:15118-15123.
49. Sato S, Cornillez-Ty C, Lazinski DW. 2004. By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber/W editing and its own expression. J. Virol. 78:8120-8134.
50. Casey JL. 2012. Control of ADAR1 editing of hepatitis delta virus RNAs. Curr. Top. Microbiol. Immunol. 353:123-143.
51. Jayan GC, Casey JL. 2002. Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2. J. Virol. 76:3819-3827.
52. Gandy SZ, Linnstaedt SD, Muralidhar S, Cashman KA, Rosenthal LJ, Casey JL. 2007. RNA editing of the human herpes virus 8 kaposin transcript eliminates its transforming activity and is induced during lytic replication. J. Virol.81:13544-13551.
53. Mishima Y, Steitz JA. 1995. Site-specific crosslinking of 4-thiouridinemodified human tRNA(3Lys) to reverse transcriptase from human immunodeficiency virus type I. EMBO J. 14:2679-2687.
54. Sontheimer EJ. 1994. Site-specific RNA crosslinking with 4-thiouridine. Mol. Biol. Rep. 20:35-44.
55. Meisenheimer KM, Koch TH. 1997. Photocross-linking of nucleic acids to associated proteins. Crit. Rev. Biochem. Mol. Biol. 32:101-140.
56. Chang J, Gudima SO, Tarn C, Nie X, Taylor JM. 2005. Development of a novel system to study hepatitis delta virus genome replication. J. Virol. 79:8182-8188.
57. Yeh TS, Lee YH. 1998. Assembly of hepatitis delta virus particles: package of multimeric hepatitis delta virus genomic RNA and role of phosphorylation. Virology 249:12-20.
58. Tawar RG, Duquerroy S, Vonrhein C, Varela PF, Damier-Piolle L, Castagne N, MacLellan K, Bedouelle H, Bricogne G, Bhella D, Eleouet JF, Rey FA. 2009. Crystal structure of a nucleocapsid-like nucleoprotein-RNA complex of respiratory syncytial virus. Science 326:1279 -1283.
59. Hastie KM, Liu T, Li S, King LB, Ngo N, Zandonatti MA, Woods VL, Jr, de la Torre JC, Saphire EO. 2011. Crystal structure of the Lassa virus nucleoprotein-RNA complex reveals a gating mechanism for RNA binding. Proc. Natl. Acad. Sci. U. S. A. 108:19365-19370.
60. Albertini AA, Wernimont AK, Muziol T, Ravelli RB, Clapier CR, Schoehn G, Weissenhorn W, Ruigrok RW. 2006. Crystal structure of the rabies virus nucleoprotein-RNA complex. Science 313:360-363.
61. Green TJ, Zhang X, Wertz GW, Luo M. 2006. Structure of the vesicular stomatitis virus nucleoprotein-RNA complex. Science 313:357-360.
62. Bayer TS, Booth LN, Knudsen SM, Ellington AD. 2005. Arginine-rich motifs present multiple interfaces for specific binding by RNA. RNA. 11: 1848-1857.
63. Pohl C, Baroudy BM, Bergmann KF, Cote PJ, Purcell RH, Hoofnagle J, Gerin JL. 1987. A human monoclonal antibody that recognizes viral polypeptides and in vitro translation products of the genome of the hepatitisD virus. J. Infect. Dis. 156:622-629.